Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 1 , Pages 35-45 , March 2006

The influence of storage conditions on delta amino levulinic acid induced toxicity and phototoxicity in vitro

References 

  1. Biel MA. Photodynamic therapy and the treatment of head and neck cancers. J Clin Laser Med Surg. 1996;14:239–244
  2. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 1997;72:595–602
  3. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neuro surgery: A review. J Photochem Photobiol B: Biol. 1997;36:157–168
  4. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wavebands of light. J Photochem Photobiol B: Biol. 1997;41:145–151
  5. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of murine tumors. Cancer Res. 1976;36:2326–2329
  6. Alian W, Andersson-Engels A, Svanberg K. Laser-induced fluorescence studies of meso-tetra(m-hydroxyphenyl) chlorin malignant and normal tissues in rats. Br J Cancer. 1994;70:880–885
  7. Morlet L, Vonarx V, Foultier MT, et al. In vitro and vivo spectrofluorimetry of a water-soluble meta-(tetrahydrophenyl)chlorin (m-THPC) derivative. J Photochem Photobiol B: Biol. 1997;39:249–257
  8. Braichotte D, Wagnieres G, Philippoz JM, et al. Clinical LIF pharmacokinetic measurements with Photofrin II for optimising the photodetection of early cancer. SPIE Proc. 1992;1645:229–240
  9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B: Biol. 1990;6:143–148
  10. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994;69:605–608
  11. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of nonmelanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;30:743–751
  12. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 1998;134:207–214
  13. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal duodenal and colorectal tumors using 5-amino levulinic acid-induced protoporphyrin IX: a pilot study. Gut. 1995;36:67–75
  14. Olivo M, Wilson BC. Mapping ALA-induced PPIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int J Oncol. 2004;25:37–45
  15. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy, clinical research and future challenges. Cancer. 1997;79:2282–2308
  16. Eleouet S, Rousset N, Carré J, et al. Heterogeneity of delta aminolevulinic acid induced protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes. Neurol Res. 2000;22:361–368
  17. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer. 1993;68:41–51
  18. Novo M, Hütmann G, Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumors. J Photochem Photobiol B: Biol. 1996;34:143–148
  19. Chang SC, MacRobert AJ, Bown SG. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol. 1996;155:1744–1748
  20. Elfsson B, Wallin I, Eksborg S, Rudaeus K, Ros AM, Ehrsson H. Stability of 5-aminolevulinic acid in aqueous solution. Eur J Pharm Sci. 1998;7:87–91
  21. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg. 1996;14:289–304
  22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983;65:55–63
  23. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barret's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;114:448–455
  24. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134:248–249
  25. Li W, Zhang WJ, Ohnishi K, Yamada I, Ohno R, Hashimoto K. 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells. J Photochem Photobiol: Biol. 2001;60:79–86
  26. Del C, Batlle AM. Porphyrins, porfirias, cancer and photodynamic therapy, a model for carcinogenesis. J Photochem Photobiol. 1993;20:5–22
  27. Moan J, Streckyte G, Bagdonas S, Bech O, Berg K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int J Cancer. 1997;70:90–97
  28. Bunke A, Zerbe O, Schmid H, Burmeister G, Merkleand HP, Gander B. Degradation mechanism and stability of 5-aminolevulinic acid. J Pharm Sci. 2000;89:1335–1341
  29. Diddens H, Hümpel B, Hüttmann G, Novo M. Chemische instabilität von 5-aminolaevulinsäure: pH und konzentrationsabhängigkeit. Lazermedizin. 1994;10:106–112
  30. De Blois AW, Grouls RJE, Ackerman EW, Wijdeven WJA. Development of a stable solution of 5-aminolaevulinic acod for intracutaneous injection in photodynamic therapy. Lasers Med Sci. 2002;17:208–215
  31. Franck B, Stratmann H. Condensation products of the porphyrin precursor 5-aminolevulinic acid to coproporphyrinogen. J Biol Chem. 1981;232:1119–1140
  32. Butler AR, George S. The nonenzymatic cyclic dimerisation of 5-aminolevulinic acid. Tetrahedron. 1992;48:7879–7886
  33. Jaffe EK, Rajagopalan JS. Nuclear magnetic resonance studies of 5-aminolevulinate demonstrate multiple forms in aqueous solution. BioChem. 1990;18:381–394
  34. Gadmar OB, Moan J, Scheie E, Ma LW, Peng Q. The stability of 5-aminolevulinic acid in solution. J Photochem Photobiol B: Biol. 2002;67:187–193
  35. Eleouet S, Rousset N, Carré J, et al. In vitro fluorescence, toxicity and phototoxicity induced by δ-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol. 2000;71:447–454
  36. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer. 1994;70:21–28
  37. MMma T, Hamblin MR, Hasan T. Hormonal modulation of the accumulation of 5-aminolevulinic acid-induced protoporphyrin and phototoxicity in prostate cancer cells. Int J Cancer. 1997;72:1062–1069
  38. Carré J, Eleouet S, Rousset N, et al. Protoporphyrin IX fluorescence kinetics in C6 glioblastoma cells after delta-aminolevulinic acid incubation: effect of a protoporphyrinogen oxidase inhibitor. Cell Mol Biol. 1999;45:433–444
  39. Bourré L, Rousset N, Thibault S, Eleouet S, Lajat Y, Patrice T. PDT effects of m-THPC and ALA, phototoxicity and apoptosis. Apoptosis. 2002;7:221–230
  40. Hanania J, Malik Z. The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett. 1992;65:127–131
  41. Shevchuk I, Chekulayev V, Moan J, Berg K. Effects of the inhibitors of energy metabolism, lonidamine and levamisole, on 5-aminolevulinic-acid-induced photochemotherapy. Int J Cancer. 1996;67:791–799
  42. Gibson SL, Havens JJ, Foster TH, Hilf R. Time-dependent intracellular accumulation of δ-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicity. Photochem. Photobiol. 1997;65:416–421
  43. Schick E, Kaufmann R, Rück A, Hainzl A, Boehncke WH. Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venereol. 1995;75:276–279
  44. Bech O, Phillips D, Moan J, MacRobert AJ. A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells. J Photochem Photobiol B: Biol. 1997;41:136–144
  45. Gaullier JM, Geze M, Santus R, et al. Subcellular localization of and photosensitization by protoporphyrin IX human keratinocytes and fibroblasts cultivated with 5-aminolevulinic acid. Photochem Photobiol. 1995;62:114–122
  46. Grebenova D, Cajthamlova H, Bartosova J, et al. Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin IX. J Photochem Photobiol B: Biol. 1998;47:74–81

PII: S1572-1000(06)00006-8

doi: 10.1016/S1572-1000(06)00006-8

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 1 , Pages 35-45 , March 2006

Article Tools

* Image Usage & Resolution